Neurologically, GLP-1 RAs demonstrate neuroprotective effects, reducing neuroinflammation and improving cognitive function in conditions like Alzheimer's and Parkinson's disease, but their association with dizziness, headaches, and psychiatric adverse effects underscores the importance of patient-specific evaluations. The gene discussed is GLP1R; the disease is Parkinson disease.